focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Infections Drop As study Backs Long AstraZeneca Jab Dose Interval

Fri, 19th Feb 2021 16:44

(Alliance News) - Coronavirus infections are dropping across the UK, new data suggests, as a study found that giving doses of the Oxford/AstraZeneca PLC vaccine 12 weeks apart improves protection.

Around one in 115 people in private households in England had Covid-19 between February 6 and 12, the Office for National Statistics (ONS) said, down from around one in 80 people from January 31 to February 6.

Meanwhile, in Wales, around one in 125 people are estimated to have had Covid-19 between February 6 and 12, down from one in 85 previously.

In Northern Ireland, the figure is around one in 105 people, down from one in 75, while in Scotland it is around one in 180 people, down from one in 150.

The data, which does not cover care homes and hospitals, is based on swab tests from thousands of people regardless of whether or not they have symptoms.

It comes as new analysis from Oxford University published in The Lancet confirmed that a single dose of the AstraZeneca vaccine offers 76% protection against Covid-19 from 22 days after vaccination, and that this had not waned by the three-month mark.

The UK policy of leaving up to 12 weeks between doses also resulted in a higher efficacy overall, the study found.

There was 81% protection when three months was left between the two doses, compared to 55% for up to a six-week interval.

The Oxford team is still urging people to have two doses of the vaccine because they say it is not yet clear how long protection with a single dose may last.

Meanwhile, government scientists put the R – the number of people an infected person will pass coronavirus on to – at 0.6 to 0.9 for the UK, compared to 0.7 to 0.9 in the previous week.

The lower end estimate is at its lowest point recorded by the scientists, and the R is below 1 in all regions of England.

However, the experts warned that "prevalence of the virus remains high, so it remains vital that everyone continues to stay at home in order to keep the R value down".

Earlier, top scientific advisers said vaccines were having an impact on the pandemic, as Prime Minister Boris Johnson prepares to publish his road map out of lockdown on Monday.

Professor Adam Finn, from the University of Bristol and a member of the Joint Committee on Vaccination and Immunisation (JCVI), said "everything's moving in the right direction" when it comes to how jabs are working.

He told BBC Radio 4's Today programme: "We've now got to the point with the study we're doing in Bristol where we can say with certainty that there is definitely an effect.

"It's just hard to put an exact number on it at this point because… the numbers of cases coming through are still building up, the number of people who've been vaccinated are still going up, but it's becoming clearer for the Pfizer Inc vaccine, which we've been using for a month longer, since early December, and it'll take slightly longer for us to get a firm handle on just how well the AstraZeneca vaccine is preventing hospitalisations too, but they're definitely doing the job."

Professor Neil Ferguson, from Imperial College London, said the data on vaccine effectiveness and how quickly infection, deaths and hospital cases were declining across the country was looking promising.

He said he thought the current lockdown should be lifted in stages, adding: "I am encouraged by the cautious approach being taken, an incremental approach which I think will be adopted, namely relax one thing and see what the impact is, relax again.

"And it still may well be that by the end of May, we're in a very different country than we are today."

Figures show a continued decline since Christmas in the number of new cases of coronavirus, although rates vary according to region.

Overall, 74,961 new cases were recorded in England in the seven days to February 14, the equivalent of 133.2 per 100,000 people.

This is down sharply from a peak of 680.8 cases per 100,000 people on January 4.

It is also the lowest seven-day rate since October 4.

Meanwhile, the number of patients in hospital in England with Covid-19 has also fallen sharply in recent weeks.

A total of 15,633 patients were in hospital as of 8am on February 18, down 54% from a record 34,336 patients exactly one month earlier.

But while this is a sizeable drop, numbers at both a national and regional level are still higher than when England came out of its second lockdown on December 2.

All regions also continue to report patient numbers well above those seen last May, when Boris Johnson announced the initial easing of the first lockdown.

Meanwhile the number of daily hospital admissions of patients with Covid-19 stood at 1,311 on February 16, down 68% from a peak of 4,134 on January 12, but still above the 1,262 on the day England came out of its second lockdown on December 2.

Elsewhere, Wales' First Minister Mark Drakeford has said some aspects of non-essential retail, as well as personal services such as hairdressing, could begin to reopen there from March 15, with stay-at-home restrictions eased in three weeks.

All primary school children in Wales are expected to return to face-to-face teaching from mid-March, while the number of people allowed to exercise together will increase from two to four.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.